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SHORT REPORT
Shigella MreB promotes polar IcsA positioning for actin
tail formation
Sina Krokowski1,2, Sharanjeet Atwal3,4,5, Damián Lobato-Márquez1,2, Arnaud Chastanet6,
Rut Carballido-López6, Jeanne Salje3,4,5 and Serge Mostowy1,2,*
ABSTRACT
Pathogenic Shigella bacteria are a paradigm to address key issues
of cell and infection biology. Polar localisation of the Shigella
autotransporter protein IcsA is essential for actin tail formation, which
is necessary for the bacterium to travel fromcell-to-cell; yet how proteins
are targeted to the bacterial cell pole is poorly understood. The bacterial
actin homologue MreB has been extensively studied in broth culture
using model organisms including Escherichia coli, Bacillus subtilis and
Caulobacter crescentus, but has never been visualised in rod-shaped
pathogenic bacteria during infection of host cells. Here, using single-cell
analysis of intracellular Shigella, we discover that MreB accumulates at
the cell pole of bacteria formingactin tails, where it colocaliseswith IcsA.
Pharmacological inhibition of host cell actin polymerisation and genetic
deletion of IcsA is used to show, respectively, that localisation ofMreB to
the cell poles precedes actin tail formation andpolar localisation of IcsA.
Finally, by exploiting the MreB inhibitors A22 and MP265, we
demonstrate that MreB polymerisation can support actin tail
formation. We conclude that Shigella MreB promotes polar IcsA
positioning for actin tail formation, and suggest that understanding the
bacterial cytoskeleton during host–pathogen interactions can inspire
development of new therapeutic regimes for infection control.
This article has an associated First Person interviewwith the first author
of the paper.
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INTRODUCTION
Shigella is a Gram-negative enteroinvasive bacterium and important
human pathogen leading to ∼164,000 deaths annually (Khalil et al.,
2018; Kotloff et al., 2017). Shigella flexneri andEscherichia coli are
closely related, but S. flexneri harbours a virulence plasmid
encoding a type III secretion system (T3SS) to inject proteins into
the host cell to promote invasion (Parsot, 2009; Sansonetti et al.,
1982). Minutes after invasion, S. flexneri escapes the phagocytic
vacuole and enters the cytosol, where it replicates and polymerises
actin tails that enable bacterial dissemination from cell-to-cell
(Welch and Way, 2013). Shigella actin-based motility relies on the
bacterial autotransporter protein IcsA, which localises to the cell
pole inside the bacterial cytosol with the help of DnaK (Janakiraman
et al., 2009), and is secreted through the inner membrane with the
help of the Sec system (Brandon et al., 2003). For localisation to the
outer membrane, IcsA requires chaperone proteins DegP, Skp and
SurA (Purdy et al., 2002, 2007). In the Shigella outer membrane,
the protease IcsP (also known as SopA) (Robbins et al., 2001),
lipopolysaccharide (LPS) (Sandlin et al., 1995) and cardiolipin (Rossi
et al., 2017) are important to maintain polar IcsA localisation. Here,
IcsA can recruit host cell neural Wiskott–Aldrich syndrome protein
(N-WASP, also known as WASL) and the actin-related protein 2/3
(Arp2/3) complex to polymerise host actin to mediate its motility
(Egile et al., 1999; Suzuki et al., 1998). However, to counteract actin-
based motility, the septin cytoskeleton can entrap actin-polymerising
Shigella in cage-like structures and target bacteria to the autophagy
pathway (Krokowski et al., 2018; Mostowy et al., 2010; Sirianni
et al., 2016), an intracellular degradation process crucial for cell
autonomous immunity (Randow et al., 2013).
The bacterial cytoskeleton regulates various cellular processes
crucial for development, including cell division and morphogenesis
(Cabeen and Jacobs-Wagner, 2010). Although mostly performed in
broth culture, rearrangement of the bacterial cytoskeleton has been the
subject of intense investigation (Surovtsev and Jacobs-Wagner, 2018).
Work has shown that the actin homologue MreB assembles into
distinct patches moving circumferentially around the bacterial cell to
organise new peptidoglycan insertion during sidewall elongation,
determining rod cell shape (Dominguez-Escobar et al., 2011; Garner
et al., 2011; van Teeffelen et al., 2011). In Caulobacter crescentus,
MreB dynamics have been proposed to establish global cell polarity
through asymmetric localisation of developmental regulators at the
cell poles (Gitai et al., 2004). Two pioneering studies artificially
producing IcsA in E. coli have proposed that MreB is required for the
restriction of polar material (Nilsen et al., 2005; Shih et al., 2005). In
this case, genetic or pharmacologic manipulation of MreB caused
IcsA to localise in multiple faint patches on the bacterial surface.
However, MreB has never been visualised in pathogenic bacteria
during infection of host cells, and the role ofMreB in IcsA positioning
has not been tested in vivo. Here, we reveal that a subpopulation of
intracellular S. flexneri cells remodel MreB, which helps to position
IcsA at the cell pole and promotes actin tail formation.
RESULTS AND DISCUSSION
MreB relocalises to the cell pole of intracellular Shigella
polymerising actin tails
We engineered S. flexneri M90T bearing a plasmid-encoded
inducible MreB-GFPsw (internal msGFP sandwich) fusion toReceived 5 October 2018; Accepted 1 April 2019
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enable us to visualise MreB during infection of host cells
(Fig. 1A,B). Considering that MreB-GFPsw is functional in E. coli
(Ouzounov et al., 2016), and that the protein sequence of E. coli
MreB and S. flexneri MreB is 100% identical (Fig. S1A), we
reasoned that MreB-GFPsw would also be functional in Shigella. In
agreement with this, production of MreB-GFPsw did not affect
Shigella cell dimensions, growth or intracellular viability during
infection, indicating that it does not perturb cell physiology
(Fig. S1B–D). Quantitative microscopy showed that for 92.3±
0.5% (mean±s.e.m.) of Shigella cells vegetatively growing in broth
culture, MreB-GFPsw forms distinct patches along the cell cylinder
(Fig. 1C,D), in agreement with the subcellular localisation of MreB-
GFPsw in E. coli (Ouzounov et al., 2016). Next, to follow MreB in
intracellular bacteria, we infected human epithelial HeLa cells with
S. flexneriMreB-GFPsw for 2 h 40 min or 3 h 40 min. In contrast to
what is seen for bacteria growing in broth culture, we found that a
subpopulation of intracellular Shigella (18.4±2.1% or 27.2±2.4%,
respectively) presents an accumulation of MreB at one bacterial cell
pole (Fig. 1C,D; Fig. S1E). In these cells, MreB is observed as a
single bright polar spot (in addition to being observed as faint
patches along the sidewall). These results suggest that a
subpopulation of intracellular Shigella remodels MreB during
infection. To test whether we could mimic intracellular conditions
that induce the polar accumulation of MreB in bacteria, we cultured
Shigella MreB-GFPsw in broth or purified HeLa cell-free extracts.
Here, we found that cell-free extracts fail to induce polar
accumulation of MreB (Fig. 1E,F). These results are in agreement
with studies showing that wild-type Shigella do not polymerise
actin in Xenopus laevis extracts because levels of IcsA are low
in vitro (Magdalena and Goldberg, 2002). We conclude that
molecular signals (host and/or bacterial) triggered during infection
of host cells are required for polar accumulation of MreB.
Considering that previous work using HeLa cells showed that
∼24% of intracellular Shigella form actin tails at 1 h 40 min post
infection (Mostowy et al., 2010), we wondered whether polar
accumulation of MreB correlates with actin tail formation. To test
this, we labelled Shigella MreB-GFPsw-infected cells for F-actin
and found that 88.1±4.2% of Shigella exhibiting polar accumulation
of MreB also polymerise actin, either as actin clouds or actin tails.
Moreover, this subpopulation is significantly more (3.1±0.5 fold)
associated with actin tails rather than actin clouds (Fig. 1G,H).
These results suggest that MreB accumulation at the cell pole of
intracellular Shigella correlates with actin tail formation.
MreB positions IcsA at the bacterial cell pole
Does actin tail formation cause MreB to accumulate at the bacterial
cell pole? To investigate this, we treated Shigella MreB-GFPsw-
infected cells with Latrunculin B (LatB), an inhibitor of eukaryotic
actin polymerisation. Fluorescence microscopy showed that LatB-
treated cells are rounded and without actin stress fibres (Fig. S2A).
Under these conditions, actin tails did not form (Fig. S2B), and
MreB localised to the bacterial cell pole as often as in untreated
conditions (Fig. 2A,B). These data show that the polar localisation
of MreB does not depend on the presence of polymerised actin,
suggesting that localisation of MreB can precede actin tail
formation.
The bacterial autotransporter protein IcsA also localises to the
Shigella cell pole before actin tail formation. Therefore, we
investigated whether polar MreB colocalises with IcsA. We
infected cells with Shigella simultaneously producing MreB-
GFPsw and IcsA507-620-mCherry [a derivative of IcsA that remains
cytosolic (Nilsen et al., 2005)] and performed quantitative Airyscan
confocal microscopy. From analysis of 900 bacterial cells, we found
that the vast majority (>95%) of Shigella cell poles that accumulate
MreB also accumulate IcsA, and vice versa (Fig. 2C,D). In line with
this, single-particle averaging (SPA) of 70 bacterial cells from
Airyscan confocal images revealed that IcsA colocalised with MreB
as a ∼0.1 µm circular spot at the cell pole for bacteria polymerising
actin tails (Fig. 2E).
To investigate the hierarchy of MreB and IcsA accumulation,
we produced MreB-GFPsw in Shigella ΔicsA cells, which are
unable to polymerise actin (Bernardini et al., 1989). During
infection of HeLa cells, we found that MreB-GFPsw localised to
the bacterial cell pole in the absence of IcsA as often as in the
presence of IcsA (Fig. 2F,G). These results show that the
localisation MreB to the cell pole precedes the polar localisation
of IcsA, and indicates a role for MreB in cytosolic positioning of
IcsA. Many other virulence factors of rod-shaped pathogenic
bacteria localise to the cell pole, including proteins important for
protein secretion and adhesion-prominent examples include the
secretion systems of Vibrio cholera (Scott et al., 2001) and
Legionella pneumophila (Conover et al., 2003), and the type IV
pilus of Pseudomonas aeruginosa (Cowles and Gitai, 2010). It
will thus be of great interest to investigate a possible conserved
role for MreB in the positioning of virulence factors.
To follow the localisation of MreB during actin-based motility,
we infected HeLa cells stably producing LifeAct-iRFP670 (to
visualise F-actin) with Shigella MreB-GFPsw for 2 h 10 min and
performed time-lapse Airyscan Fast confocal microscopy. Here, we
found that for 52.6±3.2% of bacteria polymerising actin tails, MreB
can switch between accumulating at the cell pole and localising into
patches along the cell cylinder (Fig. 2H). These data suggest that
MreB can rearrange back into patches after positioning IcsA for the
induction of actin tail formation. To test this, we determined the
length and speed of actin tails formed by bacteria that exhibit polar
MreB (exclusively), patchy MreB (exclusively) or switching MreB
(polar and patchy) during the imaging period. Here, we found that
bacteria that exhibit patchy MreB have significantly longer actin
tails and move faster, as compared to bacteria that exhibit polar
MreB and switching MreB (Fig. 2I,J). In the outer membrane, IcsA
cleavage by the protease IcsP is well known to influence actin-based
motility (Shere et al., 1997). We speculate that once actin tails are
formed, MreB switching can help to replace IcsA at the cell pole
after IcsA in the outer membrane has been cleaved by IcsP. Taken
together, these data support a model in which polar accumulation of
MreB helps to position IcsA to initiate actin tail formation but is not
strictly required during actin-based motility.
MreB polymerisation promotes Shigella actin tail formation
To investigate whether Shigella can form actin tails in the absence
of MreB polymerisation, we used the MreB inhibitor S-(3,4-
dichlorobenzyl)isothiourea (A22), an antibiotic-like small molecule
that prevents MreB polymerisation and leads to coccoid bacterial
cells (Fig. S3A,B). When added to infected cells, intracellular
bacteria became coccoid (Fig. S3C). A22 did not affect host actin
polymerisation or cell viability (Fig. S3D–F); bacterial viability is
also not affected by 2 h of A22 treatment (Fig. S3G,H). Airyscan
confocal imaging of MreB and IcsA confirmed that both proteins
are diffusely localised in the cytosol of bacteria inside A22-treated
cells (Fig. 3A). Strikingly, actin tail formation was perturbed in
A22-treated conditions, leading to significantly less (1.9±0.2 fold)
actin tails and significantly more (2.6±0.3 fold) actin clouds
(Fig. 3B,C). Similar results were obtained using the MreB inhibitor
MP265, a structural analogue of A22 (Fig. 3D,E). Taken together,
2
SHORT REPORT Journal of Cell Science (2019) 132, jcs226217. doi:10.1242/jcs.226217
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
Fig. 1. See next page for legend.
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these data reveal that inhibition of MreB polymerisation prevents
IcsA recruitment at the cell pole and reduces actin tail formation.
Septin cage entrapment reduces Shigella actin tail formation
(Mostowy et al., 2010, 2011), raising the possibility that A22-
treated bacteria form fewer actin tails due to more septin cage
entrapment. To investigate this, we treated Shigella-infected cells
with control or SEPT7 siRNA (Fig. S3I). Similar to results for cells
depleted for SEPT2 or SEPT9 (Mostowy et al., 2010), we found
significantly more (1.4±0.1 fold) actin tails in SEPT7-depleted cells
than in control cells (Fig. 3F,G). When siRNA-treated cells were
treated with A22, we observed the same amount of actin tails in
SEPT7-depleted cells as in control cells (Fig. 3F,G). These data
demonstrate that A22-treated bacteria are not entrapped in septin
cages to a greater extent than control cells, suggesting that their
defect in actin tail formation is due to inhibition of MreB
polymerisation.
To explore the role of MreB polymerisation in actin-based
motility, we performed time-lapse microscopy using LifeAct-
mCherry-transfected HeLa cells infected with Shigella expressing a
soluble GFP in untreated or A22-treated conditions. In this case,
movement of the bacteria (i.e. both the linearity and speed of
Shigella cells) is significantly reduced in the presence of A22
(Fig. 3H–J; Movies 1 and 2). Therefore, we conclude that MreB
polymerisation can promote IcsA polarisation, actin tail formation
and efficient actin-based motility.
Conclusion
The host cytoskeleton plays a crucial role in cell autonomous
immunity and offers great therapeutic potential for infection control
(Mostowy and Shenoy, 2015). Considering our discovery that MreB
promotes actin tail formation, MreB can also be viewed as a
promising target for antimicrobials. This reported biology should
encourage further work to exploit the cytoskeleton to treat bacterial
infection.
MATERIALS AND METHODS
Bacterial strains and growth conditions
Bacterial strains used in this study are found in Table S1. E. coliDH5-αwere
grown on Lysogeny Broth (LB) agar and single colonies were selected and
grown in LB broth at 37°C. Shigella strains were grown on trypticase soy
(TCS) agar containing 0.01% (w/v) Congo Red dye at 37°C. Single Congo
Red binding colonies were selected for experiments. The following
selection markers were used at the indicated concentrations: carbenicillin
(100 µg/ml) and chloramphenicol (30 µg/ml).
Cell lines
HeLa (ATCC CCL) or HeLa LifeAct-iRFP670 cells (kindly provided by
Michael Way, The Francis Crick Institute, London, UK; Snetkov et al.,
2016) were cultured in Dulbecco’s modified Eagle’s medium (DMEM;
GIBCO) supplemented with 10% fetal bovine serum (FBS) at 37°C and 5%
CO2. For selection, 10 µg/ml hygromycin was added to the culturing
medium of HeLa LifeAct-iRFP670 cells. Monthly checks for mycoplasma
contamination and other bacterial infections were performed.
Measuring bacterial growth
Shigella strains (wild-type, pBAD18 and MreB-GFPsw) were grown in TCS
broth overnight and diluted in TCS the next day to a starting optical density
at 600 nm (OD600) of 0.01. Samples were prepared in triplicates in a 96-well
plate. OD600 was measured every 30 min for 10 h at 37°C with shaking
using a microplate reader (TECAN Infinite M200 Pro).
Construction of plasmids
Constructed plasmids were sequenced at Genewiz (South Plainfield, New
Jersey). Primers and plasmids used in this study are listed in Table S1.
MreB-GFPsw was engineered in pSA10 (IPTG-induced expression) using
Advanced Quick Assembly (AQUA) cloning (Beyer et al., 2015). The
sandwich fusion consists of the GFP sequence flanked by short in-frame
linkers inserted between mreB1-684 and mreB685-1044. MreB was amplified
from S. flexneri M90 T chromosomal DNA using primers SK-67 (fw) and
SK-4 (rev) for mreB1-684 and SK-5 (fw) and SK-74 (rev) for mreB685-1044.
The monomeric superfolder GFP was amplified from plasmid pDHL584
using primers SK-3 (fw) and SK-6 (rev) and pSA10 was amplified using
primers SK-69 and SK-76. PCR products were gel purified by using a
QIAquick PCR purification kit (Qiagen), mixed in equimolar amounts and
incubated in milliQ water for 1 h at room temperature. Following this,
chemically competent E. coli were transformed with the AQUA mix, and
clones were screened for the correct assembly by performing colony PCR.
Owing to leakage of the IPTG-controlled promoter in pSA10, MreB-GFPsw
was amplified using SK-67 (fw) and SK-74 (rev) and enzymatically
transferred into pBAD18 using EcoRI and SalI. Finally, pBAD18_MreB-
GFPsw was electroporated into S. flexneri. Production of MreB-GFPsw was
suppressed by adding 1% glucose and induced by adding 0.2% arabinose to
the culture medium.
Pharmacological inhibition
For experiments involving pharmacological inhibitors, HeLa cells were
infected for 40 min followed by treatment with the inhibitor or the
corresponding solvent (control) for 2 h prior to fixation or time-lapse
microscopy. A22 was used at 4 µg/ml and MP265 was used at 1 μg/ml. To
inhibit actin polymerisation, HeLa cells were treated with 5 µM LatB for 1 h
prior to fixation.
siRNA and DNA transfection
For siRNA transfection, HeLa cells were plated in six-well plates (Thermo
Scientific) at 0.8×105 cells per well and transfected the following day with
control siRNA (Thermo Scientific AM4635) or predesigned SEPT7 siRNA
(Thermo Scientific s2753) using Oligofectamine (Thermo Scientific) for
72 h. For DNA transfection, 5×105 HeLa cells were seeded per MatTek glass-
bottom dish (MatTek corporation) including DNA and JetPEI (Polyplus
transfection), and were used 24 h later.
Antibodies
Rabbit polyclonal antibody used was anti-SEPT7 (IBL 18991, 1:500).
Mouse monoclonal antibody used was GAPDH (AbCam ab8245, 1:500).
Horseradish peroxidase-conjugated secondary antibodies used were goat
anti-rabbit-IgG (Dako P0448, 1:2000) or goat anti-mouse-IgG (Dako
Fig. 1. Shigella forming actin tails remodel MreB. (A) Diagram illustrating
the plasmid-encoded arabinose-controlled MreB-monomeric superfolder
green fluorescent protein (msGFP) sandwich fusion in S. flexneri.
(B) Localisation of MreB-GFPsw in S. flexneri in broth culture with respect to
membrane (FM4-64X) and DNA (DAPI) staining. Scale bar: 1 µm.
(C) S. flexneri MreB-GFPsw grown for 3 h in broth culture or at 3 h 40 min post
infection. Scale bar: 5 µm (main image), 1 µm (inset). (D) Graph representing
the mean±s.e.m. percentage of S. flexneri exhibiting patchy MreB-GFPsw or
accumulation of MreB-GFPsw at the bacterial cell pole. Values are from 1107
bacteria for ‘broth culture’ and 1846 bacteria for ‘host cell’ from three
independent experiments performed as in C. **P<0.01 (Student’s t-test).
(E) Representative images of S. flexneriMreB-GFPsw grown for 2 h in broth or
host cell lysates. DIC, differential interference contrast images. Scale bar:
1 µm. (F) Graph representing the mean±s.e.m. percentage of S. flexneri
exhibiting polar MreB-GFPsw accumulation. Values are from 996 bacteria for
‘broth culture’ and 933 bacteria for ‘cell lysates’ from three independent
experiments performed as in E. ns, not significant, P>0.05 (Student’s t-test).
(G) Representative images of S. flexneri MreB-GFPsw polymerising an actin
tail. HeLa cells were infected with S. flexneri MreB-GFPsw for 2 h 40 min and
labelled for F-actin. Scale bar: 1 µm. (H) Graph representing mean±s.e.m.
percentage of polar S. flexneri MreB-GFPsw that do not polymerise actin,
polymerise an actin cloud or polymerise an actin tail. Values are from 1346
bacteria from three independent experiments performed as in E., ns, not
significant, P>0.05; ***P<0.001 (one-way ANOVA). The white dashed lines in
B, the inset in C, and in E and G indicate the bacterial cell edge.
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Fig. 2. See next page for legend.
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P0260, 1:2000). F-actin was labelled with Alexa Fluor 488- or Alexa Fluor
555-conjugated phalloidin (Molecular Probes A12379 or A34055, 1:100).
Measuring cell death
HeLa cell death was quantified after treatment with 0 (CTRL), 4 or 10 μg/ml
A22 for 1 h or 2 h using 0.2% Trypan Blue and a Neubauer cell chamber. To
follow cell death over time, 104 HeLa cells were seeded in 96-well plates
(Thermo Scientific) and used for experiments 24 h later. Samples were kept
untreated or were treated with 10 μg/ml A22, and 0.05 μM SYTOX Orange
nucleic acid stain (Invitrogen) was added. Emission (535–595 nm) was
recorded hourly for 12 h using a microplate reader (TECAN Infinite
M200 Pro).
Incubation of bacterial cells with host cell lysates
HeLa cells were washed twice with PBS and once in lysate buffer (50 mM
Tris-HCl pH 8, 50 mMKCl, 0.5 mMMgCl2, 1 mMDTT, complete protease
inhibitor cocktail, 0.1 mM PMSF and 0.1% BSA). Cells were lysed with
30–40 strokes with a homogeniser, and cell lysis was confirmed by using a
light microscope. Bacterial cells were cultured in TCS broth overnight at
37°C and diluted 50× in TCS the following day. Shigella were grown to an
OD600nm of 0.4 and washed two times in TCS (CTRL) or lysate buffer.
Samples were diluted to a starting OD600nm of 0.1 and 100 µl culture was
centrifuged for 3 min at 5939 g. Bacteria were resuspended in equal volumes
of TCS (CTRL) or host cell lysates and incubated for 2 h at 37°C while
shaking. Finally, 1.5 µl bacterial culture was placed on 2% low-melting
point agarose pads for epifluorescence microscopy.
Bacterial infection of epithelial cells
HeLa (ATCC CCL) cells were cultured in DMEM (GIBCO) supplemented
with 10% fetal bovine serum (FBS) at 37°C and 5% CO2. Cells for fixed
microscopy were plated (105) on glass coverslips in six-well plates (Thermo
Scientific) and used for experiments 48 h later. HeLa cells for time-lapse
microscopy were grown (5×105) on MatTek glass-bottom dishes (MatTek
corporation) and infected 24 h later.
For infection assays, Shigellawere grown in TCS broth overnight at 37°C
and diluted 50× in TCS the following day. Bacteria were cultured until they
reached an OD600nm of 0.4–0.7. Shigellawere diluted in DMEM and added
to HeLa cells at a multiplicity of infection (MOI) of 100. Samples were
centrifuged at 110 g for 10 min at 21°C and were incubated for 30 min at
37°C and 5%CO2. To remove extracellular bacteria, cells werewashed three
times with PBS and incubated in fresh, 50 μg/ml gentamicin-containing
medium for 1 h, 1 h 30 min, 2 h or 3 h. MreB-GFPsw production was
induced with 0.2% arabinose at 40 min post infection for the remaining
infection process. IcsA507-620-mCherry, a cytosolic derivate of IcsA that
contains the region 2 targeting sequence for polar localisation (Charles et al.,
2001; Nilsen et al., 2005; a kind gift from Marcia Goldberg, Harvard
Medical School, Boston, MA), production was induced with 1 mM IPTG
15 min prior to fixation.
Gentamicin protection assays
HeLa cells were grown and infected with Shigella as described above.
Intracellular bacteria were extracted after 1 h and 4 h 40 min from infected
HeLa cells by washing with PBS and lysing the cells for 5 min with Triton-
X-100 at room temperature. Cell lysates were serially diluted and plated on
LB agar plates and incubated at 37°C overnight. The number of colony
forming units (CFU) was determined.
Fluorescence microscopy of infected cells
To process samples for fixed microscopy, infected HeLa cells were washed
with PBS and fixed in 4% paraformaldehyde (PFA) for 15 min at room
temperature, before subsequently being washed with PBS and quenched for
10 min in 0.05 M ammonium chloride at room temperature. Afterwards
cells were permeabilised for 5 min with 0.1% Triton-X-100 at room
temperature and stained for fluorescence microscopy. Incubation with
primary antibodies was performed in PBS for 1 h 30 min at room
temperature or overnight at 4°C and incubation with secondary antibodies
and phalloidin was performed in PBS for 45 min at room temperature.
Finally, cells were incubated for 10 min in 1 μg/ml DAPI and mounted in
Aqua polymount mounting medium (Polyscience Inc.). Fixed cells were
imaged using a 63×/1.4 C-Plan Apo oil immersion lens on a fluorescence-
inverted microscope Axiovert Z1 driven by ZEN software (Carl Zeiss) or on
an LSM 880 (Carl Zeiss) in Airyscan super resolution (SR) mode driven by
ZEN Black software.
For time-lapse microscopy of infected HeLa cells, samples were imaged
every 15 s in FluoroBrite (A1896701, Thermo Fisher Scientific) from 2 h
10 min after infection using a 63×/1.4 C-Plan Apo oil immersion lens on an
LSM 880 (Carl Zeiss) in Airyscan Fast SR mode driven by ZEN Black
software (Carl Zeiss) (Fig. 2H–J) or samples were imaged every 10 s in
FluoroBrite containing 50 μg/ml gentamicin from 1 h 40 min after infection
using a 63×/1.4 C-Plan Apo oil immersion lens on a confocal microscope
LSM 710 (Carl Zeiss) driven by ZEN 2010 software (Fig. 3H-J).
Microscopy of bacterial cells grown in broth culture
To measure bacterial cell length and width, wild-type Shigella and MreB-
GFPsw were grown to early exponential phase and 0.1% L-arabinose was
added for a further 2 h. Where indicated, Shigellawere treated with 3 μg/ml
FM4-64X (Thermo Scientific) for 30 min and/or 1 μg/ml DAPI for 10 min
before analysis. Bacteria were washed in PBS and 2.5 μl bacteria solution
was applied on poly-L-lysine-coated coverslips.
Microscopy analysis
Microscopy images were quantified from z-stack image series by taking 8 to
15 images over 0.2–0.4 μm. Image processing was performed using Fiji
(ImageJ) or Icy (http://icy.bioimageanalysis.org) and deconvolution was
performed using Huygens deconvolution software or ZEN software.
Bacterial cell length and width were measured manually using the plugin
‘Coli-inspector’ for FIJI. The movement (i.e. linearity and speed) of bacteria
polymerizing actin were measured using the motion profiler from Icy. For
single-particle analysis (Gray et al., 2016), the MreB-positive pole and long
axis were manually selected. All bacterial cells were automatically aligned
using these two references and the resulting stacks were averaged to create
population-representative models. Metabolically active bacteria were
quantified according to Sirianni et al. (2016).
Fig. 2. MreB and IcsA colocalise at the same bacterial cell pole. (A) HeLa
cells were infected with S. flexneri MreB-GFPsw for 1 h 40 min, treated with
LatB for 60 min and labelled for F-actin. Scale bars: 1 µm. (B) Graph
representing the mean±s.e.m. percentage of S. flexneri exhibiting polar MreB-
GFPsw localisation in untreated (CTRL) or LatB-treated conditions. Values are
from 2284 bacteria for CTRL and 1463 bacteria for LatB from three
independent experiments performed as in A. ns, not significant, P>0.05
(Student’s t-test). (C) Representative Airyscan image of HeLa cells infected for
2 h 40 min withS. flexneriMreB-GFPsw IcsA507-620-mCherry and labelled for F-
actin. Scale bar: 1 µm. (D) Graph representing the mean±s.e.m. percentage of
bacteria with polar MreB-GFPsw that also have polar IcsA507-620-mCherry and
vice versa. Values are from n=1541 bacteria from three independent
experiments performed as in C. (E) Airyscan-SPA of bacteria exhibiting polar
MreB accumulation, and resulting models for IcsA507-620-mCherry and F-actin
from n=70 bacteria. Scale bar: 1 µm. Fluorescence intensity profiles (FIP)
along the long (i) and short (ii) axis of the cell are shown to the right. Yellow
dashed lines indicate where the FIPs were taken. (F) Representative image of
HeLa cells infected with S. flexneri ΔicsA MreB-GFPsw for 2 h 40 min. Scale
bars: 1 µm. (G) Graph representing the mean±s.e.m. percentage of wild-type
(WT) or ΔicsA S. flexneri exhibiting polar MreB-GFPsw localisation. Values are
from 1622 bacteria for WT and 1634 bacteria for ΔicsA from four independent
experiments performed as in F. ns, not significant, P>0.05 (Student’s t-test).
(H) Graph representing mean±s.e.m. percentage of S. flexneri forming actin
tails exhibiting patchy or polar MreB-GFPsw localisation or switching between
patchy and polar MreB-GFPsw localisation during the imaging period. Values
are from 275 bacteria from five independent experiments performed as in
H. *P<0.05, ***P<0.001 (Student’s t-test). (I,J) Graph representing mean±s.d.
actin tail length or average speed of actin-polymerising bacteria exhibiting
patchy, polar or switching MreB-GFPsw. Each dot represents a single
bacterium from five independent experiments performed as in H. ns, not
significant,P>0.05; ***P<0.001 (Student’s t-test). Thewhite dashed lines in the
insets indicate the bacterial cell edge.
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Fig. 3. MreB polarisation promotes
Shigella actin tail formation. (A) Airyscan
image of HeLa cells infected for 40 min with S.
flexneri MreB-GFPsw IcsA507-620-mCherry,
treated for 2 h with A22 and labelled for F-
actin. Scale bar: 5 µm (main images), 1 µm
(insets). (B) S. flexneri MreB-GFPsw
polymerising actin in untreated (CTRL) and
A22-treated conditions. HeLa cells were
infected for 40 min, kept untreated or treated
with A22 for 2 h and labelled for F-actin. Scale
bars: 1 µm. (C) Graph representing the mean
±s.e.m. percentage of S. flexneri polymerising
an actin cloud or actin tail in untreated and
A22-treated conditions. Values are from 1408
bacteria for CTRL and 654 bacteria for A22
from three independent experiments
performed as in B. *P<0.05 (Student’s t-test).
(D) HeLa cells were infected withS. flexneri for
40 min, and kept untreated (CTRL) or treated
with MP265 for 2 h. They were then labelled
for F-actin using Alexa Fluor 555–phalloidin
and immunolabelled for Shigella. Scale bars:
1 µm. (E) Graph representing the mean
±s.e.m. percentage of S. flexneri polymerising
an actin cloud or actin tail in CTRL and
MP265-treated conditions. Values are from
1677 bacteria for CTRL and 1614 bacteria for
MP265 from four independent experiments
performed as in D. **P<0.01 (Student’s t-test).
(F) HeLa cells treated with control (CTRL) or
SEPT7 siRNA, infected with S. flexneri for
40 min and kept untreated (CTRL) or treated
with A22 for 2 h. Scale bars: 5 µm. (G) Graph
representing the mean±s.e.m. percentage of
S. flexneri polymerising actin tails in HeLa
cells treated with control (CTRL) siRNA or
SEPT7 siRNA and kept untreated (CTRL) or
treated with A22. Values are from 932 bacteria
for CTRL siRNA and CTRL, 852 bacteria for
CTRL siRNA and A22, 941 bacteria for
SEPT7 siRNA and CTRL and 1002 bacteria
for SEPT7 siRNA and A22 from three
independent experiments performed as in
F. ns, not significant, P>0.05; *P<0.05
(Student’s t-test). (H–J) Time-lapse images
(H) and quantifications (I,J) of HeLa cells
transfected with LifeAct-mCherry and infected
with S. flexneri GFP at 2 h 40 min post
infection imaged every 10 s in untreated
(CTRL) and A22-treated conditions. Images
are cropped from Movies 1 and 2. The white
dotted line indicates the bacterial trajectory.
Scale bars: 1 µm. Each dot represents the
linearity (I) or average speed (J) of a bacterium
polymerising actin.
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Statistics
Statistical analysis was performed in Excel (Microsoft) and Prism
Graphpad. Host cells dying from bacterial load were excluded from
analysis. In experiments using ΔicsA MreB-GFPsw Shigella cells, only
bacteria at the host cell periphery were considered for analysis to avoid
analysing overlapping bacteria. Unless otherwise indicated, data represent
the mean±standard error of the mean (s.e.m.) from at least three independent
experiments. The D’Agostino Pearson normality test was used to test
whether data are normally distributed. A Student’s t-test (unpaired, two-
tailed) or one-way ANOVAwas used to test for statistical significance, with
P<0.05 considered as significant. Fold changes were calculated from each
independent experiment and the mean±s.e.m. values are given in the text.
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